Effect of oxycodone on acute pain and anxiety after gynecological surgery

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2200062408

Enrollment

Unknown

Registered

2022-08-04

Start date

2022-08-01

Completion date

Unknown

Last updated

2023-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gynaecology

Interventions

Oxycodone group:30 minutes before the end of the operation, oxycodone 10mg/4ml was given intravenously

Control group:4ml of normal saline was given intravenously 30 minutes before the end of the operation

Eligibility

Sex/Gender

Female

Age

20 Years to 65 Years

Inclusion criteria

Inclusion criteria: 1. Patients aged 20-65 years, ASA grade I-III, ready for gynecological surgery.

Exclusion criteria

Exclusion criteria: 1. The patient has a history of severe heart disease, poorly controlled hypertension, and brain, kidney, lung, and liver diseases; 2. Anyone allergic to oxycodone; 3. Any contraindications to lidocaine, ropivacaine, midazolam sufentanil, cis-atracurium, oxycodone, propofol, diclofenac sodium; 4. Patients who are using 5HT3 blockers and have pre-existing mental illness.

Design outcomes

Primary

Measure	Time frame
Numeric rating scale, NRS;Zung Self-Rating Anxiety Scale,SAS;	—

Countries

China

Contacts

Public ContactGong Xingrui

Xiangyang Central Hospital

40415311@qq.com+86 15071551981

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026